A Detrimental Effect of Interleukin-10 on Protective Pulmonary Humoral Immunity During Primary Influenza A Virus Infection

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 2010 Mar 5

PMID 20200252

Citations 70

Authors

Keer Sun

Luisa Torres

Dennis W Metzger

Affiliations

Soon will be listed here.

Abstract

Interleukin-10 (IL-10) is an important anti-inflammatory molecule that can cause immunosuppression and long-term pathogen persistence during chronic infection of mice with viruses such as lymphocytic choriomeningitis virus. However, its specific role in immunity to acute viral infections is not fully understood. We found that IL-10 plays a detrimental role in host responses to acute influenza A virus since IL-10(-/-) mice had improved viral clearance and survival after infection compared to wild-type mice. Enhanced viral clearance in IL-10(-/-) mice was not correlated with increased CD4(+) or CD8(+) T-cell recruitment into the lung but was correlated with increased pulmonary anti-influenza virus antibody titers, and this was dependent upon the presence of T cells, primarily CD4(+) T cells. In addition, virus-specific antibody produced during the early stages of infection in the respiratory tract of IL-10(-/-) but not wild-type mice was sufficient to mediate passive protection against viral challenge of naïve mice. Complement was necessary for this antibody-mediated passive protection, but FcgammaR or neutrophil deficiency did not significantly influence viral clearance. Our results show that an absence of IL-10 at the time of primary infection leads to enhanced local virus-specific antibody production and, thus, increased protection against influenza A virus infection.

Citing Articles

Immunogenicity and Protective Efficacy of Baculovirus-Expressed SARS-CoV-2 Envelope Protein in Mice as a Universal Vaccine Candidate.

Oguzoglu T, Hanifehnezhad A, Khabbazi S, Karayel-Hacioglu I, Kaynarcalidan O, Firat Z Vaccines (Basel). 2024; 12(9).

PMID: 39340009 PMC: 11435448. DOI: 10.3390/vaccines12090977.

Ex Pluribus Unum: The CD4 T Cell Response against Influenza A Virus.

Finn C, McKinstry K Cells. 2024; 13(7.

PMID: 38607077 PMC: 11012043. DOI: 10.3390/cells13070639.

IL-10 Counteracts IFN-γ to Alleviate Acute Lung Injury in a Viral-Bacterial Superinfection Model.

McKelvey M, Uddin M, Palani S, Shao S, Sun K Am J Respir Cell Mol Biol. 2024; 71(1):110-120.

PMID: 38574279 PMC: 11225870. DOI: 10.1165/rcmb.2023-0437OC.

Beneficial and Detrimental Effects of Cytokines during Influenza and COVID-19.

Chang D, Dela Cruz C, Sharma L Viruses. 2024; 16(2).

PMID: 38400083 PMC: 10892676. DOI: 10.3390/v16020308.

Interleukin-22 suppresses major histocompatibility complex II in mucosal epithelial cells.

Moniruzzaman M, Rahman M, Wang R, Wong K, Chen A, Mueller A J Exp Med. 2023; 220(11).

PMID: 37695525 PMC: 10494524. DOI: 10.1084/jem.20230106.

References

GERHARD W . The role of the antibody response in influenza virus infection. Curr Top Microbiol Immunol. 2001; 260:171-90. DOI: 10.1007/978-3-662-05783-4_9. View

de Waal Malefyt R, Haanen J, Spits H, Roncarolo M, Te Velde A, Figdor C . Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 1991; 174(4):915-24. PMC: 2118975. DOI: 10.1084/jem.174.4.915. View

Renegar K, Small Jr P, Boykins L, Wright P . Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol. 2004; 173(3):1978-86. DOI: 10.4049/jimmunol.173.3.1978. View

Graham M, Dalton D, Giltinan D, Braciale V, Stewart T, Braciale T . Response to influenza infection in mice with a targeted disruption in the interferon gamma gene. J Exp Med. 1993; 178(5):1725-32. PMC: 2191239. DOI: 10.1084/jem.178.5.1725. View

Marcelletti J, Katz D . IL-10 stimulates murine antigen-driven antibody responses in vitro by regulating helper cell subset participation. Cell Immunol. 1996; 167(1):86-98. DOI: 10.1006/cimm.1996.0011. View

Schmitz N, Kurrer M, Bachmann M, Kopf M . Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. J Virol. 2005; 79(10):6441-8. PMC: 1091664. DOI: 10.1128/JVI.79.10.6441-6448.2005. View

Wilson E, Wille-Reece U, Dzierszinski F, Hunter C . A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol. 2005; 165(1-2):63-74. DOI: 10.1016/j.jneuroim.2005.04.018. View

Thomas P, Keating R, Hulse-Post D, Doherty P . Cell-mediated protection in influenza infection. Emerg Infect Dis. 2006; 12(1):48-54. PMC: 3291410. DOI: 10.3201/eid1201.051237. View

Corsini E, Vismara L, Lucchi L, Viviani B, Govoni S, Galli C . High interleukin-10 production is associated with low antibody response to influenza vaccination in the elderly. J Leukoc Biol. 2006; 80(2):376-82. DOI: 10.1189/jlb.0306190. View

10.

Ejrnaes M, Filippi C, Martinic M, Ling E, Togher L, Crotty S . Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med. 2006; 203(11):2461-72. PMC: 2118120. DOI: 10.1084/jem.20061462. View

11.

Brooks D, Trifilo M, Edelmann K, Teyton L, McGavern D, Oldstone M . Interleukin-10 determines viral clearance or persistence in vivo. Nat Med. 2006; 12(11):1301-9. PMC: 2535582. DOI: 10.1038/nm1492. View

12.

Maris C, Chappell C, Jacob J . Interleukin-10 plays an early role in generating virus-specific T cell anergy. BMC Immunol. 2007; 8:8. PMC: 1903364. DOI: 10.1186/1471-2172-8-8. View

13.

Bharadwaj A, Bewtra A, Agrawal D . Dendritic cells in allergic airway inflammation. Can J Physiol Pharmacol. 2007; 85(7):686-99. DOI: 10.1139/Y07-062. View

14.

Anderson C, Lira R, Kamhawi S, Belkaid Y, Wynn T, Sacks D . IL-10 and TGF-beta control the establishment of persistent and transmissible infections produced by Leishmania tropica in C57BL/6 mice. J Immunol. 2008; 180(6):4090-7. DOI: 10.4049/jimmunol.180.6.4090. View

15.

Brooks D, Lee A, Elsaesser H, McGavern D, Oldstone M . IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med. 2008; 205(3):533-41. PMC: 2275377. DOI: 10.1084/jem.20071948. View

16.

Sun K, Metzger D . Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from influenza infection. Nat Med. 2008; 14(5):558-64. DOI: 10.1038/nm1765. View

17.

Sun J, Madan R, Karp C, Braciale T . Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat Med. 2009; 15(3):277-84. PMC: 2693210. DOI: 10.1038/nm.1929. View

18.

Jaffar Z, Ferrini M, Herritt L, Roberts K . Cutting edge: lung mucosal Th17-mediated responses induce polymeric Ig receptor expression by the airway epithelium and elevate secretory IgA levels. J Immunol. 2009; 182(8):4507-11. PMC: 2740792. DOI: 10.4049/jimmunol.0900237. View

19.

McKinstry K, Strutt T, Buck A, Curtis J, Dibble J, Huston G . IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J Immunol. 2009; 182(12):7353-63. PMC: 2724021. DOI: 10.4049/jimmunol.0900657. View

20.

De Winter H, Elewaut D, Turovskaya O, Huflejt M, Shimeld C, Hagenbaugh A . Regulation of mucosal immune responses by recombinant interleukin 10 produced by intestinal epithelial cells in mice. Gastroenterology. 2002; 122(7):1829-41. DOI: 10.1053/gast.2002.33655. View